Showing results (451-460 of 600) with videos related to

Sort By:
Pageof 60
Dermatology and Therapy|October 29, 2021
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic DermatitisGil Yosipovitch, Marjolein de Bruin-Weller, April Armstrong, et al.
Annales De Chirurgie|September 15, 2000
[Vaccination by suicide gene therapy against a model of hepatic metastasis from colon cancer in the rat]A Gavelli, P Baqué, M Mala, et al.
Nature Communications|February 20, 2025
Topologically cloaked magnetic colloidal transportAnna M E B Rossi, Thomas Märker, Nico C X Stuhlmüller, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 30, 2025
Facial Rash Events in Dupilumab Phase 3 Atopic Dermatitis Trials: A Pooled AnalysisAmy S Paller, Marjolein de Bruin-Weller, Eric L Simpson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 9, 2021
Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic studyJonathan I Silverberg, Sebastien Barbarot, Abhijit Gadkari, et al.
Dermatology and Therapy|August 24, 2021
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and OlderEric L Simpson, Amy S Paller, Elaine C Siegfried, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 24, 2008
Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient studyJ Ring, A Abraham, C de Cuyper, et al.
Dermatology and Therapy|December 13, 2021
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term TreatmentApril Armstrong, Andrew Blauvelt, Eric L Simpson, et al.
The Journal of Cell Biology|March 27, 2001
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx miceY Torrente, J P Tremblay, F Pisati, et al.
JAMA Dermatology|February 1, 2023
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical TrialsAmy S Paller, Jonathan I Silverberg, Michael J Cork, et al.
Pageof 60